Beam Therapeutics Inc. (BEAM) reported Loss for its first quarter that increased from last year and missed the Street estimates.
The company's bottom line totaled -$109.27 million, or -$1.24 per share. This compares with -$98.67 million, or -$1.21 per share, last year.
Analysts on average had expected the company to earn -$1.17 per share. Analysts' estimates typically exclude special items.
Beam Therapeutics Inc. earnings at a glance (GAAP) :
-Earnings: -$109.27 Mln. vs. -$98.67 Mln. last year.
-EPS: -$1.24 vs. -$1.21 last year.
For comments and feedback: editorial@rttnews.com